SCHEMBL3272567

SCHEMBL3272567

O=Cc1ccc2c(F)cccc2c1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.44
TYMS P04818 1/20 0.39
PIM1 P11309 2/20 0.36
PIM3 Q86V86 2/20 0.36
HTT P42858 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PABPC1 P11940 1/20 0.33
TRIM24 O15164 2/20 0.32
TRIM33 Q9UPN9 2/20 0.32
CYP2A6 P11509 4/20 0.32
IMPDH2 P12268 1/20 0.32
PIM2 Q9P1W9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9797604 0.82 KMT2A (0.42) ERN1PIM1PIM3HTTSMN1; SMN2
SCHEMBL31620481 0.81 PIM1 (0.45) TYMSPIM1PIM3HTTSMN1; SMN2
SCHEMBL1170296 0.78 ERN1 (0.57) ERN1HTTSMN1; SMN2ALDH1A1MEN1
SCHEMBL9671258 0.78 ERN1 (0.57) ERN1TYMSHTTSMN1; SMN2ALDH1A1
SCHEMBL12143561 0.78 ERN1 (0.57) ERN1TYMSHTTSMN1; SMN2ALDH1A1
SCHEMBL3267169 0.78 CYP2A6 (0.48) TYMSPIM1PIM3HTTSMN1; SMN2
SCHEMBL29951202 0.74 ERN1 (0.47) ERN1HTTSMN1; SMN2ALDH1A1MEN1
SCHEMBL485577 0.74 ERN1 (0.47) ERN1HTTSMN1; SMN2ALDH1A1MEN1
Hydrochloric Acid SCHEMBL28960226 0.72 ERN1 (0.45) ERN1HTTSMN1; SMN2ALDH1A1MEN1
SCHEMBL8491593 0.71 ERN1 (0.43) ERN1ALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1914229-B1 NOVEL CERCOSPORAMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-06-16 EP disclosed
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed
CN-101300244-A Novel cercosporamide derivative DAIICHI SANKYO CO LTD (JP) 2008-11-05 CN disclosed
EP-1914229-A1 NOVEL CERCOSPORAMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 ERN1 337/4885TYMS 4095/4885PIM1 819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.